CClinicalTrials.gg
CompletedNCT01371903CapnoUpdated Mar 24, 2014

The Effects of Patient Features on Opioid Induced End-Tidal CO2

An observational study in Opioid Use During Medical Care, sponsored by Albany Medical College. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-03-24.

Sponsored by Albany Medical College · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
278
Ages
18 Years and older
Sex
All
01

Study summary

Emergency department patients receiving opioid pain medicine such as morphine, fentanyl or Dilaudid are eligible. After medication exhaled carbon dioxide is measured. and recorded.

Read the detailed description

Emergency department patients receiving opioid pain medicine such as morphine, fentanyl, or Dilaudid are eligible. After receiving the pain medication, a small soft plastic tube will be placed between the upper lip and nose. This tube is used to measure the amount of carbon dioxide the patient is breathing out. It can also be used to deliver oxygen if the provider feels the patient needs it. The carbon dioxide breathed out is measured and collected. Other information collected are height, weight, and vital signs. Patient participation time is approximately 2 hours during the emergency department visit.

02

Conditions studied

  • Opioid Use During Medical Care

Keywords

  • morphine
  • fentanyl
  • dilaudid
  • opioid
  • capnography
03

In context

Lead sponsor

Albany Medical College is the lead sponsor of 80 studies on the registry; 14 are open to participants now.

Of its 17 completed or terminated interventional studies of FDA-regulated products, 3 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients receiving opioid such as morphine, fentanyl, or dilaudid during their emergency department visit.

Inclusion criteria

  • non intubated patients receiving intravenous opioid medications

Exclusion criteria

Exclusion Criteria:

  • mechanically ventilated patients
  • patients with physiologic shock
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
278 participants (actual)
06

What researchers measure

Primary outcomes

  1. end tidal carbon dioxide

    measured through small nasal cannula (plastic tube at base of nares)

    Time frame: study start, 30 minutes, 60 minutes, 90 minutes, 120 minutes

07

Study locations

1 site
  • Albany Medical Center Emergency Department
    Albany, New York 12208, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 24, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01371903
Lead sponsor
Albany Medical College
Responsible party
Wayne Triner (Professor Emergency Medicine, Albany Medical College) — Principal investigator
First posted
Jun 13, 2011
Start date
Aug 2010
Primary completion
Nov 2012
Completion
Nov 2012
Last update
Mar 24, 2014

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion